Comment from Stephanie Alsup
AnonymousOpposeIndividual
Summary: An individual patient expresses strong opposition to the proposed action, arguing that it would restrict access to affordable compounded GLP-1 medications. They state that these medications are life-changing and necessary for patients who face significant cost barriers or lack insurance coverage.
I strongly oppose efforts to stop compounded GLP-1 medications. Many patients (including myself) rely on compounded medication options due to cost barriers or lack of insurance coverage. These medications have been life-changing for me and others. Removing access would disproportionately harm patients who already face financial and healthcare disparities. Please continue to allow safe compounding practices so patients can maintain access to medically necessary treatment.